# Shanghai United Imaging Healthcare Co. Ltd. A (688271.SHG)

Canonical: https://gigainvestors.com/s/688271.SHG

Analysis as of: 2026-10-16T07:35:23.569Z. 

Listing currency: CNY. Reporting currency: CNY.

## Verdict

Not enough history yet

Quality tests for Buy: not passed (profit record: pass; earnings resilience is evidence only). Published buy qualification: no.

Share price: CNY 107.41 per share; close as of 2026-10-15.

## Checklist

### understandable: na

### moat: na

### economics: na

### management: na

### accounting: na

## Holders

## Price story

Down 49% since Oct 2022

Story as of 2026-10-16T10:01:26.943Z; price observation 2026-10-15.

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in medical devices; annual sales are CNY 13.8 billion.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2025-12-31 (filed 2026-10-16T07:35:23.569Z); FY2025: revenue 13800251663.95; grossProfit 6487669216.99; margin = grossProfit / revenue.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); 688271.SHG: Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company provides molecular imaging products; and magnetic resonance imaging solutions. It also offers computed tomography equipment; digital radiography equipment; mammography equipment; angiography equipment; mobile C-arm equipment; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; a low-dose, 3D mammography platform; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software used to analyze functional magnetic resonance imaging and diffusion tensor imaging data, and U-VIEWER, software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China.

### Why customers stay

Margins ranged from 47% to 48.5% during 2023–25.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2023-12-31 (filed 2026-10-16T07:35:23.569Z); FY2023: grossProfit / revenue = 47.1%.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2024-12-31 (filed 2026-10-16T07:35:23.569Z); FY2024: grossProfit / revenue = 48.5%.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2025-12-31 (filed 2026-10-16T07:35:23.569Z); FY2025: grossProfit / revenue = 47%.

### Where the cash goes

Spends 81.3% of cash earnings on expansion; paid dividends in 6 of 6 years.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2020-12-31 (filed 2026-10-16T07:35:23.569Z); FY2020: growth capex 0; upkeep 702573872.49; owner earnings 391843464.86. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2021-12-31 (filed 2026-10-16T07:35:23.569Z); FY2021: growth capex 98787894.78999999; upkeep 247948688.09; owner earnings 1396075970.184. Growth capex / owner earnings = 0.07076111680153047.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2022-12-31 (filed 2026-10-16T07:35:23.569Z); FY2022: growth capex 463129039.91999996; upkeep 278206177.11; owner earnings 1635729928.152. Growth capex / owner earnings = 0.28313294997495686.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2023-12-31 (filed 2026-10-16T07:35:23.569Z); FY2023: growth capex 647230815.2892299; upkeep 428594192.55077004; owner earnings 1867890082.08323. Growth capex / owner earnings = 0.34650369499654016.

- Source: https://eodhd.com/api/fundamentals/688271.SHG.json#2025-12-31 (filed 2026-10-16T07:35:23.569Z); FY2025: growth capex 1233940831.4534478; upkeep 859241133.7565522; owner earnings 1517251861.1514478. Growth capex / owner earnings = 0.8132735658778535.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:35:23.569Z); Dividend observations: [[2020,56681500.17],[2021,8105298.16],[2022,956788.36],[2023,165950046.78],[2024,303596850.17],[2025,176081824.06]]. Zero only counted when supported by a complete cash-flow statement.

### Are managers owners

Insiders own 56.6% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16); 688271.SHG SharesStats.PercentInsiders = 56.589999999999996 percentage points; cache date 2026-10-16.

### What the price says

The price is 6.4 times annual sales.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-16T07:35:23.569Z); Closing price 107.41 CNY; reporting-to-trading FX 1; FY2025 annual sales per share 16.83226889666858; price multiple 6.381195586844411. FY2025 cash earnings/share 1.850603302951806. Closing-price date 2026-10-15.

## Monthly share-price history (CNY per share)

- 2022-08: CNY 172.00 per share

- 2022-09: CNY 181.60 per share

- 2022-10: CNY 210.50 per share

- 2022-11: CNY 185.50 per share

- 2022-12: CNY 176.98 per share

- 2023-01: CNY 181.90 per share

- 2023-02: CNY 168.01 per share

- 2023-03: CNY 154.24 per share

- 2023-04: CNY 145.72 per share

- 2023-05: CNY 135.63 per share

- 2023-06: CNY 138.01 per share

- 2023-07: CNY 141.99 per share

- 2023-08: CNY 110.27 per share

- 2023-09: CNY 104.09 per share

- 2023-10: CNY 119.36 per share

- 2023-11: CNY 143.00 per share

- 2023-12: CNY 137.01 per share

- 2024-01: CNY 134.88 per share

- 2024-02: CNY 142.30 per share

- 2024-03: CNY 129.80 per share

- 2024-04: CNY 132.56 per share

- 2024-05: CNY 127.80 per share

- 2024-06: CNY 109.70 per share

- 2024-07: CNY 116.25 per share

- 2024-08: CNY 105.71 per share

- 2024-09: CNY 128.00 per share

- 2024-10: CNY 122.18 per share

- 2024-11: CNY 131.15 per share

- 2024-12: CNY 126.40 per share

- 2025-01: CNY 124.39 per share

- 2025-02: CNY 134.95 per share

- 2025-03: CNY 121.99 per share

- 2025-04: CNY 132.90 per share

- 2025-05: CNY 137.43 per share

- 2025-06: CNY 127.74 per share

- 2025-07: CNY 133.30 per share

- 2025-08: CNY 141.80 per share

- 2025-09: CNY 151.70 per share

- 2025-10: CNY 139.92 per share

- 2025-11: CNY 133.10 per share

- 2025-12: CNY 125.50 per share

- 2026-01: CNY 129.30 per share

- 2026-02: CNY 130.70 per share

- 2026-03: CNY 112.00 per share

- 2026-04: CNY 109.95 per share

- 2026-05: CNY 120.30 per share

- 2026-06: CNY 101.23 per share

- 2026-07: CNY 115.52 per share

- 2026-08: CNY 104.50 per share

- 2026-09: CNY 107.37 per share

- 2026-10: CNY 106.24 per share

## Annual estimated value (CNY per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations